Multiple Sclerosis Trial, Recruiting NCT07573241 Sponsor: University of Washington Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT07573241
Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with multiple sclerosis (MS) of any type, as confirmed by their medical records.
  • People who have experienced at least moderate pain on average over the past week (a score above 3 on a 0–10 pain scale).
  • People who have had pain on more than half of the days over the past 3 months.
  • People who are able to follow the study procedures and fill out questionnaires on their own using a mobile phone.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are under 18 years of age.
  • People who score higher than 8 on a standard MS disability scale called the Expanded Disability Status Scale, which measures how much MS affects daily functioning (confirm with trial site).
  • People who show significant memory or thinking difficulties, based on making one or more errors on a short 6-question cognitive screening test.
  • People who have changed their MS medications in the past 3 months — though a person may be considered once 3 months have passed since the change.
  • People who have had an MS relapse (a flare-up of symptoms) within the past 30 days — though a person may be considered once 30 days have passed.
  • People who are currently having thoughts of suicide with a plan or intention to act on them, based on screening questionnaires — though people who have thoughts of suicide without any intent or plan may still be considered.
  • People who are currently receiving psychological therapy (such as counselling or therapy sessions) specifically for pain.
  • People who already have an established mindfulness practice, meaning they practise mindfulness more than 3 days per week.
  • People who are unable to read or speak English.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

If you need support right now

This page includes language about suicide and self-harm, because that is how the trial's eligibility criteria are written. If reading it has been hard, you do not have to keep going. The services below are free, confidential, and answered by people trained for exactly this.

If you or someone else is in immediate danger, call 000.

  • Lifeline — 24/7 crisis support: 13 11 14
  • Suicide Call Back Service — 24/7 counselling: 1300 659 467
  • 13YARN — 24/7, for Aboriginal and Torres Strait Islander people: 13 92 76
  • Beyond Blue — 24/7 mental health support: 1300 22 4636
  • Emergency: 000

Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention. If you are in immediate danger, call your local emergency number.

Voxsanity is not a crisis service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.

Contact this trial

Principal Investigator: Erin Mistretta, PhD, University of Washington

Phone: 206-668-4168

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 July 2026
Est. completion
31 December 2027

Primary endpoints

Daily Mindfulness Practice

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov